SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
刘春艳
Lv1
40 积分
2023-03-28 加入
最近求助
最近应助
互助留言
Frontline Promise for Adagrasib-Pembrolizumab Combination
27天前
已关闭
LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
30天前
已完结
OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
30天前
已完结
OA03.06 CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC
30天前
已完结
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma
1个月前
已完结
Wnt/β-catenin Signaling Inhibitors
2个月前
已完结
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting
3个月前
已完结
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer
3个月前
已完结
Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals
3个月前
已完结
Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals
3个月前
已完结
没有进行任何应助
帮大忙了
30天前
感谢,点赞,速度真快
30天前
谢谢
1个月前
谢谢
3个月前
xiexie
3个月前
谢谢谢谢
4个月前
非常感谢
5个月前
谢谢您
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论